Increased transcriptional expression of Epstein-Barr virus (EBV) BamHI-A Rightward Transcripts: RPMS, BARF0 and A73 in EBV-associated nasopharyngeal carcinoma patients

Thuan Duc Lao, Tuan Hoang Anh Nguyen, Dung Huu Nguyen, Thuy Huyen Ai Le


Background: In Vietnam, nasopharyngeal carcinoma (NPC) is the most common cancer of head and neck cancers, with a high rate of cancer deaths. Epstein-Barr virus (EBV) infection has been reported to be an etiological factor of NPC. The transcripts from the Bam A rightward transcripts (BamHI-A) region, including BARF0, RPMS1 and A73, which mapped to EBV genome, have been indicated to play a pivotal role in EBV biological stage. However, the profile of target genes in Vietnamese NPC patients has not been investigated.

Purpose: The aims of current study were to evaluate the expression and assess whether or not BARF0, RPMS1 and A73 transcripts associated to Vietnamese NPC.

Materials and methods: Total of RNA was isolated from 30 NPC biopsy and 30 noncancerous swab samples were analyzed by RT-qPCR. The 2-ΔΔCt method was applied to evaluate the relative expression of each target gene by q-PCR.

Results: The higher frequency of BARF0, RPMS1 and A73 detection were 66.67%, 90.00%, and 70.00%, respectively, in NPC samples (p < 0.05). Additionally, the BARF0, RPMS1 and A73 transcripts were overexpressed by 9.58, 10.22 and 20.58 times in NPC samples compared to noncancerous samples. Additionally, the highest OR and RR values were 29.00 (95% CI = 3.49 – 241.14), and 2.75 (95% CI = 1.79 – 4.23), respectively, observed in the case of combination of detected three genes compared to individual genes.

Conclusion: Taking together, it could be concluded that BARF0, RPMS1 and A73 transcripts were upregulated in NPC, and maybe further serve as potential diagnostic biomarkers for NPC in local population. 


BARTs; BARF0; RPMS1; A73; Nasopharyngeal carcinoma


Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from burkitt's lymphoma. Lancet. 1964;1:702-03.

Baumforth KR, Young LS, Flavell KJ, Constandinou C, Murray PG. The Epstein-Barr virus and its association with human cancers. Mol Pathol. 1999;52:307-22.

Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 2002;12:431-41.

Vranic S, Cyprian FS, Akhtar S, Al Moustafa A-E. The Role of Epstein–Barr Virus in Cervical Cancer: A Brief Update. Frontiers in Oncology. 2018;8:113.

Tsurumi T, Fujita M, Kudoh A. Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol. 2005;15:3-15.

Young LS, Dawson CW, Eliopoulos AG. The expression and function of Epstein-Barr virus encoded latent genes. Molecular Pathology. 2000;5:238-47.

Marquitz AR, Raab-Traub N. The role of miRNAs and EBV BARTs in NPC. Semin Cancer Biol. 2012;22:166-72.

Gilligan KJ, Rajadurai P, Lin JC, Busson P, Abdel-Hamid M, Prasad U, et al. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol. 1991;65:6252-59.

Smith PR, de Jesus O, Turner D, Hollyoake M, Karstegl CE, Griffin BE, et al. Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol. 2000;74:3082-92.

de Jesus O, Smith PR, Spender LC, Elgueta Karstegl C, Niller HH, Huang D, et al. Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol. 2003;84(Pt 6):1443-50.

Smith P. Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer. Semin Cancer Biol. 2001;11:469-76.

Zhang J, Chen H, Weinmaster G, Hayward SD. Epstein-Barr virus BamHi-a rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC. J Virol. 2001;75:2946-56.

Li A, Zhang XS, Jiang JH, Wang HH, Liu XQ, Pan ZG, et al. Transcriptional expression of RPMS1 in nasopharyngeal carcinoma and its oncogenic potential. Cell Cycle. 2005;4:304-9.

Kienzle N, Sculley TB, Poulsen L, Buck M, Cross S, Raab-Traub N, et al. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. J Virol. 1998;72:6614-20.

Al-Mozaini M, Bodelon G, Karstegl CE, Jin B, Al-Ahdal M, Farrell PJ. Epstein-Barr virus BART gene expression. J Gen Virol. 2009;90(Pt 2):307-16.

Mahdavifar N, Ghoncheh M, Mohammadian-Hafshejani A, Khosravi B, Salehiniya H. Epidemiology and Inequality in the Incidence and Mortality of Nasopharynx Cancer in Asia. Osong Public Health Res Perspect. 2016;7:360-72.

Feng FT, Cui Q, Liu WS, Guo WM, Feng QS, Chen LZ, et al. A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma. Chin J Cancer. 2015;34:563-72.

Lin JH, Tsai CH, Chu JS, Chen JY, Takada K, Shew JY. Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells. J Virol. 2007;81:5705-13.

van Beek J, Brink AA, Vervoort MB, van Zijp MJ, Meijer CJ, van den Brule AJ, et al. In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders. J Gen Virol. 2003;84(Pt 10):2647-59.

Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad Sci U S A. 1994;91:7568-72.

Höfelmayr H, Strobl LJ, Stein C, Laux G, Marschall G, Bornkamm GW, et al. Activated mouse Notch1 transactivates Epstein-Barr virus nuclear antigen 2-regulated viral promoters. J Virol. 1999;73:2770-80.


  • There are currently no refbacks.